Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-025605
Filing Date
2022-09-12
Accepted
2022-09-12 14:10:04
Documents
39
Period of Report
2022-07-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 340314
2 form10-q_001.jpg GRAPHIC 5948
3 ex31-1.htm EX-31.1 17511
4 ex32-1.htm EX-32.1 13665
  Complete submission text file 0001493152-22-025605.txt   1789058

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bqst-20220731.xsd EX-101.SCH 16393
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bqst-20220731_cal.xml EX-101.CAL 26540
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bqst-20220731_def.xml EX-101.DEF 39035
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bqst-20220731_lab.xml EX-101.LAB 137430
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bqst-20220731_pre.xml EX-101.PRE 103308
33 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 148817
Mailing Address 4570 CAMPUS DRIVE #23 NEWPORT BEACH NEWPORT BEACH CA 92660
Business Address 4570 CAMPUS DRIVE #23 NEWPORT BEACH NEWPORT BEACH CA 92660 418-264-7134
Bioquest Corp (Filer) CIK: 0001568628 (see all company filings)

EIN.: 990378854 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-56260 | Film No.: 221238298
SIC: 2834 Pharmaceutical Preparations